Publications by authors named "Birgit Bollbuck"

6Publications

Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.

Authors:
Shin Numao Franziska Hasler Claire Laguerre Honnappa Srinivas Nathalie Wack Petra Jäger Andres Schmid Arnaud Osmont Patrik Röthlisberger Jeremy Houguenade Christian Bergsdorf Janet Dawson Nathalie Carte Andreas Hofmann Christian Markert Liz Hardaker Andreas Billich Romain M Wolf Carlos A Penno Birgit Bollbuck Wolfgang Miltz Till A Röhn

Sci Rep 2017 10 19;7(1):13591. Epub 2017 Oct 19.

Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.

View Article and Find Full Text PDF
October 2017

Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism.

Authors:
Marc Bigaud Zuhal Dincer Birgit Bollbuck Janet Dawson Nicolau Beckmann Christian Beerli Gina Fishli-Cavelti Michaela Nahler Daniela Angst Philipp Janser Heike Otto Elisabeth Rosner Rene Hersperger Christian Bruns Jean Quancard

PLoS One 2016 22;11(12):e0168252. Epub 2016 Dec 22.

Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland.

View Article and Find Full Text PDF
July 2017

An oral sphingosine 1-phosphate receptor 1 (S1P(1)) antagonist prodrug with efficacy in vivo: discovery, synthesis, and evaluation.

Authors:
Daniela Angst Philipp Janser Jean Quancard Peter Buehlmayer Frederic Berst Lukas Oberer Christian Beerli Markus Streiff Charles Pally Rene Hersperger Christian Bruns Frederic Bassilana Birgit Bollbuck

J Med Chem 2012 Nov 26;55(22):9722-34. Epub 2012 Oct 26.

Novartis Pharma AG, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.

View Article and Find Full Text PDF
November 2012

A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis.

Authors:
Jean Quancard Birgit Bollbuck Philipp Janser Daniela Angst Frédéric Berst Peter Buehlmayer Markus Streiff Christian Beerli Volker Brinkmann Danilo Guerini Paul A Smith Timothy J Seabrook Martin Traebert Klaus Seuwen René Hersperger Christian Bruns Frédéric Bassilana Marc Bigaud

Chem Biol 2012 Sep;19(9):1142-51

Novartis Institutes for Biomedical Research, CH-4056 Basel, Switzerland.

View Article and Find Full Text PDF
September 2012

Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.

Authors:
Rudolf Waelchli Birgit Bollbuck Christian Bruns Thomas Buhl Jörg Eder Roland Feifel Rene Hersperger Philipp Janser Laszlo Revesz Hans-Günter Zerwes Achim Schlapbach

Bioorg Med Chem Lett 2006 Jan 19;16(1):108-12. Epub 2005 Oct 19.

Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
January 2006

Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis.

Authors:
Laszlo Revesz Birgit Bollbuck Thomas Buhl Joerg Eder Ronald Esser Roland Feifel Richard Heng Peter Hiestand Benedicte Jachez-Demange Pius Loetscher Helmut Sparrer Achim Schlapbach Rudolf Waelchli

Bioorg Med Chem Lett 2005 Dec 28;15(23):5160-4. Epub 2005 Sep 28.

Novartis Institutes for BioMedical Research, Global Discovery Chemistry, Autoimmunity and Transplantation, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
December 2005